Skip to main content
. 2020 Dec 31:pvaa138. doi: 10.1093/ehjcvp/pvaa138

Figure 1.

Figure 1

Study selection (PRISMA flow diagram). ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; CoViD-19, coronavirus disease 2019; PRISMA, preferred reporting items for systematic reviews and meta-analyses; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2.